Filana Therapeutics, Inc. (FLNA)

Filana Therapeutics experienced six insider trading transactions over the past ninety days, all representing open market purchases. Executives, including the CEO, CFO, and COO, acquired shares totaling approximately 627,549 USD. This activity follows a period of significant stock price decline and precedes the next scheduled earnings report in March 2027.
Ticker: FLNA Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Filana Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
377.48
Quantity 23,287 +0.5%
Value US$63,047
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
83.75
Quantity 82,302 +2.7%
Value US$4,748,240
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
117.56
Quantity 14,895 -42.1%
Value US$1,980,418
1.5
Cook Robert Christopher Chief Operating& Legal Officer Officer
Transaction date
Purchase
Price
0.46
Quantity 1,000 +885.8%
Value US$100,000
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
0.92
Quantity 100,000 +8.1%
Value US$92,000
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
0.90
Quantity 206,813 +20.1%
Value US$186,132
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
0.84
Quantity 93,091 +9.9%
Value US$78,196
0.6
Anderson Robert Eugene Jr Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 8,600 New position
Value US$24,940
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.76
Quantity 150,000 +19.0%
Value US$414,000
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.75
Quantity 73,385 +10.3%
Value US$201,809
1.5
Cook Robert Christopher Chief Operating & Legal Office Officer
Transaction date
Purchase
Price
2.91
Quantity 13,725 New position
Value US$39,940
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.28
Quantity 7,172 +1.0%
Value US$16,352
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.29
Quantity 46,908 +7.1%
Value US$107,419
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.25
Quantity 400 +0.1%
Value US$900
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.24
Quantity 185,233 +39.0%
Value US$414,922
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.13
Quantity 5,400 +1.2%
Value US$11,502
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 59,800 -83.9%
Value US$230,828
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Sale
Price
3.82
Quantity 2,000 -100.0%
Value US$7,640
2.3
Kupiec James William Chief Medical Officer Officer
Transaction date
Sale
Price
3.87
Quantity 4,000 -100.0%
Value US$15,480
3.0
Schoen, Eric J. (SAVA) Officer Officer
Transaction date
Proposed sale
Price
3.82
Quantity 2,000
Value US$7,640
3.0
Schoen Eric Officer Officer
Transaction date
Proposed sale
Price
3.86
Quantity 59,800
Value US$230,966
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
17.45
Quantity 30,000 +3.5%
Value US$523,500
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
16.65
Quantity 16,571 +6.0%
Value US$275,907
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
16.80
Quantity 1,906 +0.7%
Value US$32,021
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
25.76
Quantity 77,276 +39.1%
Value US$1,990,630
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
26.13
Quantity 11,565 +6.2%
Value US$302,193
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
23.79
Quantity 36,159 +24.1%
Value US$860,223
2.3
Kupiec James William Chief Clinical Dev. Officer Officer
Transaction date
Purchase
Price
24.44
Quantity 2,500 New position
Value US$61,100
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
20.69
Quantity 100,000 +10.8%
Value US$2,069,000
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
19.95
Quantity 2,500 +14.5%
Value US$49,875
1.5
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
9.59
Quantity 10,000 +0.9%
Value US$95,900
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
8.92
Quantity 36,281 +4.1%
Value US$323,627
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
7.04
Quantity 2,000 +7.9%
Value US$14,080
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
6.98
Quantity 213,719 +32.3%
Value US$1,491,759
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
7.03
Quantity 10,000 +65.4%
Value US$70,300
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
5.53
Quantity 100,000 +10.3%
Value US$553,000
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
4.15
Quantity 10,000 +1.0%
Value US$41,500
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
2.20
Quantity 423,788 +177.4%
Value US$932,334
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.86
Quantity 76,212 +46.9%
Value US$141,754
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
1.88
Quantity 5,300 +53.0%
Value US$9,964
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
1.65
Quantity 2,599 New position
Value US$4,288
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
1.06
Quantity 10,000 New position
Value US$10,600
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
1.31
Quantity 512,660 -23.7%
Value US$671,738
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 37,817 +30.3%
Value US$39,708
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 30,992 +33.0%
Value US$32,542
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 21,420 +29.6%
Value US$21,420
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
0.96
Quantity 9,771 +15.6%
Value US$9,380
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.91
Quantity 8,000 -0.4%
Value US$7,254
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.95
Quantity 48,000 -2.2%
Value US$45,682
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 1,200,000 -35.1%
Value US$1,222,200
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
3.76
Quantity 31,838 +9.4%
Value US$119,711
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
3.69
Quantity 18,162 +5.7%
Value US$67,018
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.44
Quantity 25,000 -8.8%
Value US$111,008
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.75
Quantity 50,000 -1.2%
Value US$237,500
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.50
Quantity 265,000 -5.8%
Value US$1,193,162
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.59
Quantity 7,000 -2.4%
Value US$32,118
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.83
Quantity 67,000 -1.4%
Value US$323,409
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.89
Quantity 8,000 -2.7%
Value US$39,122
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.91
Quantity 10,000 -3.2%
Value US$49,060
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.89
Quantity 25,000 -7.5%
Value US$122,125
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.20
Quantity 44,417 -0.9%
Value US$186,600
BARBIER REMI CEO, Chairman of the Board Executive Director Large shareholder
Transaction date
Purchase
Price
4.22
Quantity 5,000 +0.1%
Value US$21,095
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
6.13
Quantity 15,000 -0.3%
Value US$91,950
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.60
Quantity 16,264 -0.3%
Value US$91,078
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.87
Quantity 11,097 -0.2%
Value US$65,139
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.81
Quantity 6,468 -0.1%
Value US$37,586
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.53
Quantity 9,496 -0.2%
Value US$52,541
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-19 2026-11-17 B Purchase

President & CEO

Executive Director
23,287 +0.5%
377.48
US$63,047
23,287 +0.5% 377.48 US$63,047
2026-11-18 2026-11-16 B Purchase

President & CEO

Executive Director
82,302 +2.7%
83.75
US$4,748,240
82,302 +2.7% 83.75 US$4,748,240
2026-11-18 2026-11-16 B Purchase

Chief Financial Officer

Officer
14,895 -42.1%
117.56
US$1,980,418
14,895 -42.1% 117.56 US$1,980,418
2026-11-18 2026-11-16 B Purchase

Chief Operating& Legal Officer

Officer
1,000 +885.8%
0.46
US$100,000
1,000 +885.8% 0.46 US$100,000
2026-10-01 2026-09-30 B Purchase

President & CEO

Executive Director
100,000 +8.1%
0.92
US$92,000
100,000 +8.1% 0.92 US$92,000
2026-10-01 2026-09-29 B Purchase

President & CEO

Executive Director
206,813 +20.1%
0.90
US$186,132
206,813 +20.1% 0.90 US$186,132
2026-09-30 2026-09-28 B Purchase

President & CEO

Executive Director
93,091 +9.9%
0.84
US$78,196
93,091 +9.9% 0.84 US$78,196
2025-11-25 2025-11-24 B Purchase Non-Executive Director
8,600 New position
2.90
US$24,940
8,600 New position 2.90 US$24,940
2025-11-24 2025-11-20 B Purchase

President & CEO

Executive Director
150,000 +19.0%
2.76
US$414,000
150,000 +19.0% 2.76 US$414,000
2025-11-20 2025-11-19 B Purchase

President & CEO

Executive Director
73,385 +10.3%
2.75
US$201,809
73,385 +10.3% 2.75 US$201,809
2025-10-02 2025-09-30 B Purchase

Chief Operating & Legal Office

Officer
13,725 New position
2.91
US$39,940
13,725 New position 2.91 US$39,940
2025-09-23 2025-09-22 B Purchase

President & CEO

Executive Director
7,172 +1.0%
2.28
US$16,352
7,172 +1.0% 2.28 US$16,352
2025-09-22 2025-09-19 B Purchase

President & CEO

Executive Director
46,908 +7.1%
2.29
US$107,419
46,908 +7.1% 2.29 US$107,419
2025-09-22 2025-09-19 B Purchase

President & CEO

Executive Director
400 +0.1%
2.25
US$900
400 +0.1% 2.25 US$900
2025-09-22 2025-09-18 B Purchase

President & CEO

Executive Director
185,233 +39.0%
2.24
US$414,922
185,233 +39.0% 2.24 US$414,922
2025-09-22 2025-09-18 B Purchase

President & CEO

Executive Director
5,400 +1.2%
2.13
US$11,502
5,400 +1.2% 2.13 US$11,502
2024-12-03 2024-11-29 S Sale

Chief Financial Officer

Officer
59,800 -83.9%
3.86
US$230,828
59,800 -83.9% 3.86 US$230,828
2024-12-03 2024-11-29 S Sale

Chief Financial Officer

Officer
2,000 -100.0%
3.82
US$7,640
2,000 -100.0% 3.82 US$7,640
2024-12-03 2024-11-29 S Sale

Chief Medical Officer

Officer
4,000 -100.0%
3.87
US$15,480
4,000 -100.0% 3.87 US$15,480
2024-12-02 2024-11-29 PrS Proposed sale

Officer

Officer
2,000
3.82
US$7,640
2,000 3.82 US$7,640
2024-11-29 2024-11-29 PrS Proposed sale

Officer

Officer
59,800
3.86
US$230,966
59,800 3.86 US$230,966
2023-08-24 2023-08-23 B Purchase Non-Executive Director
30,000 +3.5%
17.45
US$523,500
30,000 +3.5% 17.45 US$523,500
2023-08-23 2023-08-22 B Purchase Non-Executive Director
16,571 +6.0%
16.65
US$275,907
16,571 +6.0% 16.65 US$275,907
2023-08-23 2023-08-21 B Purchase Non-Executive Director
1,906 +0.7%
16.80
US$32,021
1,906 +0.7% 16.80 US$32,021
2023-03-08 2023-03-07 B Purchase Non-Executive Director
77,276 +39.1%
25.76
US$1,990,630
77,276 +39.1% 25.76 US$1,990,630
2023-03-08 2023-03-06 B Purchase Non-Executive Director
11,565 +6.2%
26.13
US$302,193
11,565 +6.2% 26.13 US$302,193
2022-08-25 2022-08-23 B Purchase Non-Executive Director
36,159 +24.1%
23.79
US$860,223
36,159 +24.1% 23.79 US$860,223
2022-08-24 2022-08-23 B Purchase

Chief Clinical Dev. Officer

Officer
2,500 New position
24.44
US$61,100
2,500 New position 24.44 US$61,100
2022-08-16 2022-08-12 B Purchase Non-Executive Director
100,000 +10.8%
20.69
US$2,069,000
100,000 +10.8% 20.69 US$2,069,000
2022-08-16 2022-08-12 B Purchase

Chief Financial Officer

Officer
2,500 +14.5%
19.95
US$49,875
2,500 +14.5% 19.95 US$49,875
2020-09-24 2020-09-24 B Purchase

President and CEO

Executive Director
10,000 +0.9%
9.59
US$95,900
10,000 +0.9% 9.59 US$95,900
2020-09-21 2020-09-18 B Purchase Non-Executive Director
36,281 +4.1%
8.92
US$323,627
36,281 +4.1% 8.92 US$323,627
2020-09-17 2020-09-17 B Purchase

Chief Financial Officer

Officer
2,000 +7.9%
7.04
US$14,080
2,000 +7.9% 7.04 US$14,080
2020-09-17 2020-09-17 B Purchase Non-Executive Director
213,719 +32.3%
6.98
US$1,491,759
213,719 +32.3% 6.98 US$1,491,759
2020-09-17 2020-09-17 B Purchase

Chief Financial Officer

Officer
10,000 +65.4%
7.03
US$70,300
10,000 +65.4% 7.03 US$70,300
2019-12-31 2019-12-31 B Purchase BARBIER REMI

President and CEO

Executive Director
100,000 +10.3%
5.53
US$553,000
100,000 +10.3% 5.53 US$553,000
2019-12-26 2019-12-26 B Purchase BARBIER REMI

President and CEO

Executive Director
10,000 +1.0%
4.15
US$41,500
10,000 +1.0% 4.15 US$41,500
2019-12-20 2019-12-20 B Purchase ROBERTSON SANFORD Non-Executive Director
423,788 +177.4%
2.20
US$932,334
423,788 +177.4% 2.20 US$932,334
2019-12-19 2019-12-19 B Purchase ROBERTSON SANFORD Non-Executive Director
76,212 +46.9%
1.86
US$141,754
76,212 +46.9% 1.86 US$141,754
2019-12-19 2019-12-19 B Purchase Schoen Eric

Chief Financial Officer

Officer
5,300 +53.0%
1.88
US$9,964
5,300 +53.0% 1.88 US$9,964
2019-12-20 2019-12-18 B Purchase BARBIER REMI

President and CEO

Executive Director
2,599 New position
1.65
US$4,288
2,599 New position 1.65 US$4,288
2019-05-15 2019-05-14 B Purchase

Chief Financial Officer

Officer
10,000 New position
1.06
US$10,600
10,000 New position 1.06 US$10,600
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
512,660 -23.7%
1.31
US$671,738
512,660 -23.7% 1.31 US$671,738
2018-09-27 2018-09-27 B Purchase ROBERTSON SANFORD Non-Executive Director
37,817 +30.3%
1.05
US$39,708
37,817 +30.3% 1.05 US$39,708
2018-09-26 2018-09-26 B Purchase ROBERTSON SANFORD Non-Executive Director
30,992 +33.0%
1.05
US$32,542
30,992 +33.0% 1.05 US$32,542
2018-09-26 2018-09-25 B Purchase ROBERTSON SANFORD Non-Executive Director
21,420 +29.6%
1.00
US$21,420
21,420 +29.6% 1.00 US$21,420
2018-09-26 2018-09-24 B Purchase ROBERTSON SANFORD Non-Executive Director
9,771 +15.6%
0.96
US$9,380
9,771 +15.6% 0.96 US$9,380
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
8,000 -0.4%
0.91
US$7,254
8,000 -0.4% 0.91 US$7,254
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
48,000 -2.2%
0.95
US$45,682
48,000 -2.2% 0.95 US$45,682
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0
0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
1,200,000 -35.1%
1.02
US$1,222,200
1,200,000 -35.1% 1.02 US$1,222,200
2013-11-07 2013-11-06 B Purchase ROBERTSON SANFORD Non-Executive Director
31,838 +9.4%
3.76
US$119,711
31,838 +9.4% 3.76 US$119,711
2013-11-07 2013-11-04 B Purchase ROBERTSON SANFORD Non-Executive Director
18,162 +5.7%
3.69
US$67,018
18,162 +5.7% 3.69 US$67,018
2011-10-24 2011-10-18 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -8.8%
4.44
US$111,008
25,000 -8.8% 4.44 US$111,008
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
50,000 -1.2%
4.75
US$237,500
50,000 -1.2% 4.75 US$237,500
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
265,000 -5.8%
4.50
US$1,193,162
265,000 -5.8% 4.50 US$1,193,162
2011-10-04 2011-10-04 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
7,000 -2.4%
4.59
US$32,118
7,000 -2.4% 4.59 US$32,118
2011-10-05 2011-10-03 S Sale Sabretooth Master Fund, L.P. Large shareholder
67,000 -1.4%
4.83
US$323,409
67,000 -1.4% 4.83 US$323,409
2011-10-04 2011-10-03 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
8,000 -2.7%
4.89
US$39,122
8,000 -2.7% 4.89 US$39,122
2011-10-04 2011-09-30 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
10,000 -3.2%
4.91
US$49,060
10,000 -3.2% 4.91 US$49,060
2011-09-21 2011-09-15 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -7.5%
4.89
US$122,125
25,000 -7.5% 4.89 US$122,125
2011-08-10 2011-08-08 S Sale Sabretooth Master Fund, L.P. Large shareholder
44,417 -0.9%
4.20
US$186,600
44,417 -0.9% 4.20 US$186,600
2011-08-08 2011-08-08 B Purchase BARBIER REMI

CEO, Chairman of the Board

Executive Director Large shareholder
5,000 +0.1%
4.22
US$21,095
5,000 +0.1% 4.22 US$21,095
2010-10-04 2010-10-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
15,000 -0.3%
6.13
US$91,950
15,000 -0.3% 6.13 US$91,950
2010-09-08 2010-09-07 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
16,264 -0.3%
5.60
US$91,078
16,264 -0.3% 5.60 US$91,078
2010-09-02 2010-09-02 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
11,097 -0.2%
5.87
US$65,139
11,097 -0.2% 5.87 US$65,139
2010-08-10 2010-08-09 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,468 -0.1%
5.81
US$37,586
6,468 -0.1% 5.81 US$37,586
2010-08-10 2010-08-06 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
9,496 -0.2%
5.53
US$52,541
9,496 -0.2% 5.53 US$52,541

See older Filana Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Filana Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime